Terapevticheskii arkhivTerapevticheskii arkhivТерапевтический архив0040-36602309-5342LLC Obyedinennaya Redaktsiya70367510.26442/00403660.2026.05.203676Editorial articleПередовая статьяReview ArticleThe problem of osteoarthritis in patients with atopyПроблема остеоартрита у пациентов с атопиейhttps://orcid.org/0000-0003-2641-9785BeketovaTatiana V.БекетоваТатьяна Валентиновна
Russian Federation

д-р мед. наук, вед. науч. сотр., зав. отд-нием ревматологии с нефрологическими койками и кабинетом терапии генно-инженерными биологическими препаратами

doc@tvbek.ruhttps://orcid.org/0000-0002-1598-8360NasonovEvgeny L.НасоновЕвгений Львович
Russian Federation

акад. РАН, д-р мед. наук, проф., науч. рук.

doc@tvbek.ruNasonova Research Institute of RheumatologyФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой» Минобрнауки РоссииCentral Clinical Hospital with PolyclinicФГБУ «Центральная клиническая больница с поликлиникой» Управления делами Президента РФMoscow Polytechnic UniversityФГАОУ ВО «Московский политехнический университет» Минобрнауки России13062026985Issues of rheumatologyВопросы ревматологии2702740303202616042026Copyright ©; 2026, Consilium MedicumCopyright ©; 2026, ООО "Консилиум Медикум"2026Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://ter-arkhiv.ru/0040-3660/article/view/703675

The problem of osteoarthritis (OA) in patients with atopy (bronchial asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis) discussed. In patients with atopy, the risk of OA is significantly higher (36–58%) than in the general population. Possible mechanisms of OA in atopy are considered. Further research may help decipher the pathogenesis of OA and improve pharmacotherapy.

Обсуждается концепция взаимосвязи остеоартрита (ОА) и атопических заболеваний (бронхиальной астмы, атопического дерматита, аллергического ринита, аллергического конъюнктивита), при которых риск ОА значительно выше (на 36–58%), чем в общей популяции. Рассматривается возможная общность механизмов ОА и атопии, углубленное изучение которых может способствовать уточнению патогенеза ОА и совершенствованию фармакотерапии.

osteoarthritisatopybronchial asthmaatopic dermatitisallergic rhinitisallergic conjunctivitisостеоартритатопиябронхиальная астмаатопический дерматиталлергический риниталлергический конъюнктивитSwain S, Sarmanova A, Coupland C, et al. Comorbidities in Osteoarthritis: A Systematic Review and Meta-Analysis of Observational Studies. Arthritis Care Res (Hoboken). 2020;72(7):991-1000. DOI:10.1002/acr.24008Courties A, Kouki I, Soliman N, et al. Osteoarthritis year in review 2024: Epidemiology and therapy. Osteoarthritis Cartilage. 2024;32(11): 1397-404. DOI:10.1016/j.joca.2024.07.014Алексеева Л.И., Раскина Т.А., Таскина Е.А., и др. Мультиморбидность и плейотропные эффекты базисных препаратов, применяемых для лечения остеоартрита. Научно-практическая ревматология. 2025;63(4):331-7 [Alekseeva LI, Raskina TA, Taskina EA, et al. Multimorbidity and pleiotropic effects of basic drugs used for the treatment of osteoarthritis. Rheumatology Science and Practice. 2025;63(4): 331-7 (in Russian)]. DOI:10.47360/1995-4484-2025-331-337Трошина Е.А., Паневин Т.С., Брискман Т.Д. Роль ожирения в развитии и прогрессировании остеоартрита: влияние медикаментозных и хирургических методов лечения ожирения на течение воспалительных заболеваний суставов. Терапевтический архив. 2025;97(5):449-54 [Troshina EA, Panevin TS, Briskman TD. The role of obesity in the development and progression of osteoarthritis: the influence of medical and surgical therapies for obesity on the course of inflammatory arthritis: A review. Terapevticheskii Arkhiv (Ter. Arkh.). 2025;97(5):449-54 (in Russian)]. DOI:10.26442/00403660.2025.05.203230Wang Q, Lepus CM, Raghu H, et al. IgE-mediated mast cell activation promotes inflammation and cartilage destruction in osteoarthritis. Elife. 2019;8:e39905. DOI:10.7554/eLife.39905Baker MC, Sheth K, Lu R, et al. Increased risk of osteoarthritis in patients with atopic disease. Ann Rheum Dis. 2023;82(6):866-72. DOI:10.1136/ard-2022-223640Li YS, Luo W, Zhu SA, Lei GH. T Cells in Osteoarthritis: Alterations and Beyond. Front Immunol. 2017;8:356. DOI:10.3389/fimmu.2017.00356Rezuș E, Cardoneanu A, Burlui A, et al. The Link Between Inflammaging and Degenerative Joint Diseases. Int J Mol Sci. 2019;20(3):614. DOI:10.3390/ijms20030614Defois A, Bon N, Charpentier A, et al. Osteoarthritic chondrocytes undergo a glycolysis-related metabolic switch upon exposure to IL-1b or TNF. Cell Commun Signal. 2023;21(1):137. DOI:10.1186/s12964-023-01150-zWu Z, Luo X, Dou P, et al. Asthma, social isolation and loneliness, and risk of incident osteoarthritis. Arthritis Res Ther. 2025;27(1):29. DOI:10.1186/s13075-025-03496-wPark D, Choi YH, Han K, et al. Risk of knee osteoarthritis in patients with multiple atopic conditions: a nationwide study. Sci Rep. 2025;15(1):15293. DOI:10.1038/s41598-025-92247-7Wang H, Chen M, Wang T, et al. Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis. Front Immunol. 2025;16:1539997. DOI:10.3389/fimmu.2025.1539997Wu LC, Hwang CY, Chung PI, et al. Autoimmune disease comorbidities in patients with atopic dermatitis: a nationwide case-control study in Taiwan. Pediatr Allergy Immunol. 2014;25(6):586-92. DOI:10.1111/pai.12274Lin CH, Lin CL, Shen TC, Wei CC. Epidemiology and risk of juvenile idiopathic arthritis among children with allergic diseases: a nationwide population-based study. Pediatr Rheumatol Online J. 2016;14(1):15. DOI:10.1186/s12969-016-0074-8Lai NS, Tsai TY, Koo M, Lu MC. Association of rheumatoid arthritis with allergic diseases: A nationwide population-based cohort study. Allergy Asthma Proc. 2015;36(5):99-103. DOI:10.2500/aap.2015.36.3871Takanashi S, Akiyama M, Furuhashi K, et al. Distinct impact of malignancy and allergy on the clinical and immunological features of IgG4-related disease. Clin Exp Rheumatol. 2023;41(9):1754-61. DOI:10.55563/clinexprheumatol/7g2na0Akiyama M, Alshehri W, Ishigaki S, et al. The immunological pathogenesis of IgG4-related disease categorized by clinical characteristics. Immunol Med. 2025;48(1):11-23. DOI:10.1080/25785826.2024.2407224Vaseghi-Shanjani M, Samra S, Yousefi P, et al. Primary atopic disorders: inborn errors of immunity causing severe allergic disease. Curr Opin Immunol. 2025;94:102538. DOI:10.1016/j.coi.2025.102538Magnusson K, Turkiewicz A, Rydén M, Englund M. Genetic Influence on Osteoarthritis Versus Other Rheumatic Diseases. Arthritis Rheumatol. 2024;76(2):206-15. DOI:10.1002/art.42696Weldingh E, Johnsen MB, Hagen KB, et al. The Maternal and Paternal Effects on Clinically and Surgically Defined Osteoarthritis. Arthritis Rheumatol. 2019;71(11):1844-8. DOI:10.1002/art.41023Spector TD, MacGregor AJ. Risk factors for osteoarthritis: genetics. Osteoarthritis Cartilage. 2004;12(Suppl. A):S39-44. DOI:10.1016/j.joca.2003.09.005Anker-Hansen C, Pirouzifard M, Sundquist J, et al. Familial risks of five types of osteoarthritis in first-, second- and third-degree relatives – A nationwide Swedish family study. Osteoarthr Cartil Open. 2025;7(3):100637. DOI:10.1016/j.ocarto.2025.100637Forster T, Chapman K, Loughlin J. Common variants within the interleukin 4 receptor alpha gene (IL4R) are associated with susceptibility to osteoarthritis. Hum Genet. 2004;114(4):391-5. DOI:10.1007/s00439-004-1083-0Vargiolu M, Silvestri T, Bonora E, et al. Interleukin-4/interleukin-4 receptor gene polymorphisms in hand osteoarthritis. Osteoarthritis Cartilage. 2010;18(6):810-6. DOI:10.1016/j.joca.2010.02.005Yigit S, Inanir A, Tekcan A, et al. Significant association of interleukin-4 gene intron 3 VNTR polymorphism with susceptibility to knee osteoarthritis. Gene. 2014;537(1):6-9. DOI:10.1016/j.gene.2013.12.060Kim S. Relationship between Osteoarthritis and Atopic Dermatitis Based on the 3rd-8th Korea National Health and Nutrition Examination Survey. Korean J Geriatr Gerontol. 2024;25(1):49-59. DOI:10.15656/kjgg.2024.25.1.49Di J, Song L, Liu Y, et al. Eosinophil-to-Lymphocyte Ratio and Eosinophil Count as New Predictive Markers for Osteoarthritis. J Pain Res. 2024;17:3803-15. DOI:10.2147/JPR.S480925Montelukast for the treatment of erosive hand osteoarthritis. WIPO. Publication Number WO/2020/109230. Available at: https://patentscope.wipo.int/search/en/WO2020109230. Accessed: 20.02.2026.Ponce L, Arjona M, Blanco G, et al. The effect of montelukast in a model of gouty arthritis induced by sodium monourate crystals. Invest Clin. 2011;52(1):15-22.Dong H, Liu F, Ma F, et al. Montelukast inhibits inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. Int Immunopharmacol. 2018;61:215-21. DOI:10.1016/j.intimp.2018.04.042Bihlet A, Miller C, Byrjalsen I, et al. Antihistamine Use and Structural Progression of Knee OA: A Post-Hoc Analysis of Two Phase 3 Clinical Trials [abstract]. Arthritis Rheumatol. 2022;74(Suppl. 9). Available at: https://acrabstracts.org/abstract/antihistamine-use-and-structural-progression-of-knee-oa-a-post-hoc-analysis-of-two-phase-3-clinical-trials/. Accessed: 20.02.2026.Zúñiga VA, Bazan-Perkins B. The impact of vitamin D on atopic disorders: assessing evidence for a causal relationship. Front Nutr. 2025;12:1584818. DOI:10.3389/fnut.2025.1584818Кашеварова Н.Г., Алексеева Л.И., Таскина Е.А., и др. Взаимосвязь витамина D и остеоартрита. Терапевтический архив. 2025;97(5):434-42 [Kashevarova NG, Alekseeva LI, Taskina EA, et al. Relationship between vitamin D and osteoarthritis. Terapevticheskii Arkhiv (Ter. Arkh.). 2025;97(5):434-42 (in Russian)]. DOI:10.26442/00403660.2025.05.203228Jay R, Rodger J, Zirwas M. Review of dupilumab-associated inflammatory arthritis: An approach to clinical analysis and management. JAAD Case Rep. 2022;21:14-8. DOI:10.1016/j.jdcr.2021.12.011See Tow HX, Yew YW. Joint Pain and Inflammatory Arthropathy after Dupilumab Use in Atopic Dermatitis: A Systematic Review and Meta-Analysis. Dermatitis. 2026;37(2):205-23. DOI:10.1089/derm.2025.0038Hanania NA, Niven R, Chanez P, et al. Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma. World Allergy Organ J. 2022;15(10):100695. DOI:10.1016/j.waojou.2022.100695Dupin C, Valéry S, Guilleminault L, et al. Articular manifestations related to anti-interleukin-5 therapies in severe asthma: a case series. ERJ Open Res. 2024;10(1):00935-2023. DOI:10.1183/23120541.00935-2023Andreev D, Liu M, Kachler K, et al. Regulatory eosinophils induce the resolution of experimental arthritis and appear in remission state of human rheumatoid arthritis. Ann Rheum Dis. 2021;80(4):451-68. DOI:10.1136/annrheumdis-2020-218902Qin Y, Jin HZ, Li YJ, Chen Z. Emerging Role of Eosinophils in Resolution of Arthritis. Front Immunol. 2021;12:764825. DOI:10.3389/fimmu.2021.764825Kamata M, Tada Y. Optimal Use of Jak Inhibitors and Biologics for Atopic Dermatitis on the Basis of the Current Evidence. JID Innov. 2023;3(3):100195. DOI:10.1016/j.xjidi.2023.100195Georas SN, Donohue P, Connolly M, Wechsler ME. JAK inhibitors for asthma. J Allergy Clin Immunol. 2021;148(4):953-63. DOI:10.1016/j.jaci.2021.08.013Chiu YS, Bamodu OA, Fong IH, et al. The JAK inhibitor Tofacitinib inhibits structural damage in osteoarthritis by modulating JAK1/TNF-alpha/IL-6 signaling through Mir-149-5p. Bone. 2021;151:116024. DOI:10.1016/j.bone.2021.116024